Sildenafil for Early Pulmonary Vascular Disease in Scleroderma
Sildenafil for Early Pulmonary Vascular Disease in Scleroderma
Recruiting · NCT04797286 · Registry updated 2026-09-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Sildenafil for Early Pulmonary Vascular Disease in Scleroderma | Skin and Connective Tissue Diseases, connective tissue disorder, diffuse scleroderma, scleroderma, skin disorder, systemic sclerosis | Recruiting | Phase 2 | 2026-09-28 | NCT04797286 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Johns Hopkins University | 579 |
| Louisiana State University Health Sciences Center in New Orleans | 20 |
| United States Department of Defense | 319 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Johns Hopkins | Baltimore | United States | 39 |
| Louisiana State University | New Orleans | United States | 1 |